GALT
#3263
Galectin Therapeutics Inc. - Common Stock
4.9 2 USD
-0.08%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-7.87%
Monthly Change
+87.79%
6 month change
+59.74%
Year Change
+75.71%
Previous Close
5.3 4
Open
4.8 5
Low
4.8 2
High
4.9 7
Volume
88
Financials
- Market Capitalization 324.02 M
- Employee 9
- Founded 2000
- CEO N/A
- Website www.galectintherapeutics.com
- Headquarter Nevada, United States
- FIGI BBG000BK6FP5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-6.8
Price to sales ratio
-69.49
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3245 |  PALI Palisade Bio, Inc. - Common Stock | 2.04 USD | +5.70% | +3.03% | +21.43% | +20.00% | 354.10 M USD | ||
| 3259 |  INDP Indaptus Therapeutics, Inc. - Common Stock | 2.98 USD | +13.31% | +23.14% | -21.37% | +56.84% | 337.46 M USD | ||
| 3267 |  CTNM Contineum Therapeutics, Inc. - Common stock | 14.33 USD | -1.65% | -8.84% | +13.10% | -6.16% | 331.01 M USD | ||
| 3279 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 14.32 USD | +6.87% | -4.72% | +7.19% | -40.80% | 334.14 M USD |
Frequently asked questions about Galectin Therapeutics Inc. - Common Stock
What is the Galectin Therapeutics Inc. - Common Stock stock price today?
The current price of Galectin Therapeutics Inc. - Common Stock (GALT) is 4.92. Over the past 24 hours, the stock has changed by -7.87%. Follow the GALT chart for real-time price dynamics.
What is the stock ticker of Galectin Therapeutics Inc. - Common Stock?
Galectin Therapeutics Inc. - Common Stock trades under the ticker GALT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Galectin Therapeutics Inc. - Common Stock stock going up?
GALT has changed by +6.96% over the last week, +87.79% over the last month, and +75.71% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Galectin Therapeutics Inc. - Common Stock net income for the last quarter?
Galectin Therapeutics Inc. - Common Stock reported net income of -5.05 M for the last quarter. The previous quarter showed -5.5 M, which means net income changed by +8.25%.
How many employees does Galectin Therapeutics Inc. - Common Stock have?
As of the latest available data, Galectin Therapeutics Inc. - Common Stock has 9 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Galectin Therapeutics Inc. - Common Stock stock?
You can buy Galectin Therapeutics Inc. - Common Stock (GALT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Galectin Therapeutics Inc. - Common Stock stock?
Investing in Galectin Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GALT chart and related analysis on metatrader.com as part of your research.